An open labelled non-randomized phase II clinical trial to evaluate the efficacy of KARASEELAI an external therapy in the management of VIRANAM (skin ulcer)

An open labelled non-randomized phase II clinical trial to evaluate the efficacy of KARASEELAI an external therapy in the management of VIRANAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053018

Enrollment

Registered

2023-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L984- Non-pressure chronic ulcer of skin, not elsewhere classified

Interventions

Intervention1: KARASEELAI: External application for 15 days Intervention2: KARASEELAI: External apply in affected area once a day for 15 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Acute and chronic ulcers 2.Patient who are willing for admission and stay in IPD or willing to attend OPD 3.Patient who are willing to give blood samples for laboratory investigations

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.Severe renal,hepatic,cardiac disease 3.Malignant ulcers 4.Uncontrolled diabetes 5.Syphilitic ulcers

Design outcomes

Primary

Measure	Time frame
Pain decreased and healing of the ulcer expectedTimepoint: 15 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDrMAhamed Mohideen MDS

Government siddha medical College and hospital, Palayamkottai

dr.ahmed63@gmail.com9442542282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026